Chronic Gut Inflammation Associated With Onset of Parkinson Disease
June 10th 2021The results of the study are consistent with several large-scale epidemiological studies that show an association between Parkinson and inflammatory bowel diseases, such as ulcerative colitis and Crohn disease.
Read More
Diets Including Whole Fruits May Decrease Risk of Developing Type 2 Diabetes
June 3rd 2021Researchers found an association between fruit intake and markers of insulin sensitivity, which meant that people who consumed more fruit had to produce less insulin to lower their blood glucose levels.
Read More
Early-Onset Colorectal Cancer Linked to Higher Red Meat Consumption, Poorer Education
May 27th 2021Incidence rates of early-onset colorectal cancer in the United States have increased from 8.6 to 13.1 per 100,000 between 1992 and 2013, with most of this increase attributable to early-onset cancers of the rectum.
Read More
Mathematical Model of the Brain May Identify Gene Changes Responsible for Cognitive Decline in Aging
May 24th 2021According to the study authors, this model provides insights into the multiscale biological alterations in the elderly and neurodegenerative brain, which have important implications for identifying treatment targets for Alzheimer disease.
Read More
Study Shows Cancer Vaccine May Boost Immunotherapy Effectiveness
May 21st 2021The investigators found that using the vaccine in combination with an immune checkpoint inhibitor—an established immunotherapy drug with a 20% success rate overall for patients—can vastly improve the proportion of individuals who respond to treatments, eliminating tumors in 75% of cases in mice.
Read More
Topline results from the phase 2/3 XIRIUS study of cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients with X-linked retinitis pigmentosa (XLRP), found that the study did not meet its primary endpoint of demonstrating a statistically significant improvement in the proportion of treated study eyes.
Read More
Combination Immunotherapy Provides Potential Benefits in Controlling, Reducing HIV
May 19th 2021A combination immunotherapy of interleukin-21 (IL-21) and interferon alpha (IFN-alpha) in combination with antiretroviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models.
Read More